Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MLL3 mutation + TMB-H
i
Other names:
MLL3, KMT2C, Lysine Methyltransferase 2C, Histone-Lysine N-Methyltransferase 2C, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 3, Lysine (K)-Specific Methyltransferase 2C, Histone-Lysine N-Methyltransferase, H3 Lysine-4 Specific, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3, Histone-Lysine N-Methyltransferase MLL3, Lysine N-Methyltransferase 2C, ALR-Like Protein, KLEFS2, TMB | Tumor Mutational Burde
Associations
(3)
News
Trials
B | Sensitive
C3 | Sensitive
B | Resistant
C3 | Resistant
Show legend
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Non Small Cell Lung Cancer
Colorectal Cancer
PD1 inhibitor + CTLA4 inhibitor
B
MLL3 mutation + TMB-H
|
Non Small Cell Lung Cancer
|
PD1 inhibitor + CTLA4 inhibitor
PD-L1 inhibitor
B
MLL3 mutation + TMB-H
|
Non Small Cell Lung Cancer
|
PD-L1 inhibitor
Immunotherapy
C3
MLL3 mutation + TMB-H
|
Colorectal Cancer
|
Immunotherapy
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login